ImmunityBio Builds Industrial Workforce with the Appointment of Seasoned Advertising and Reimbursement Executives

Biopharma leaders deliver verified market place progress talents in urology and oncology to bolster company’s commercialization system and extensive-phrase growth plans

  • Helen Luu, previous CEO of Cell BT, is named ImmunityBio’s 1st Chief Commercial Officer and brings a robust background in product or service commercialization in the urology industry, business growth, income expansion, and oncology industry growth.

  • Sigrid Schreiner joins as Senior Vice President of World Market place Obtain, including decades of market entry encounter to the leadership team, like the sector start of chemotherapy Abraxane®.

CULVER City, Calif., September 07, 2021–(Company WIRE)–ImmunityBio, Inc. (NASDAQ: IBRX),

Read more